Stock Events

Stock Events

Denali Therapeutics (DNLI) Q4 2023 Earnings

27FebConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.86

-0.14

0.58

1.3

Details

Expected EPS

-0.803996

Actual EPS

-0.86

Surprise EPS

-0.06

Surprise Percent

+6.97%

Description

Denali Therapeutics (DNLI) has reported earnings of -0.86 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.